Fluorescence Enhancement of Warfarin Induced by Interaction with β-CyclodextrinVASQUEZ, Jacob M; VU, Andrew; SCHULTZ, Jerome S et al.Biotechnology progress. 2009, Vol 25, Num 4, pp 906-914, issn 8756-7938, 9 p.Conference Paper

Reversible endotension associated with excessive warfarin anticoagulationIYER, Vikram S; MACKENZIE, Kent S; CORRIVEAU, Marc-Michel et al.Journal of vascular surgery. 2007, Vol 45, Num 3, pp 600-602, issn 0741-5214, 3 p.Article

WARFARIN THERAPY : INFLUENCE OF PHARMACOGENETIC AND ENVIRONMENTAL FACTORS ON THE ANTICOAGULANT RESPONSE TO WARFARINSIGURET, Virginie; PAUTAS, Eric; GOUIN-THIBAULT, Isabelle et al.Vitamins and hormones. 2008, Vol 78, pp 247-264, issn 0083-6729, 18 p.Article

Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspectiveHIRSH, Jack.Thrombosis and haemostasis. 2014, Vol 112, Num 5, pp 853-856, issn 0340-6245, 4 p.Article

Warfarin embryopathy: fetal manifestationsWAINWRIGHT, Helen; BEIGHTON, Peter.Virchows Archiv. 2010, Vol 457, Num 6, pp 735-739, issn 0945-6317, 5 p.Article

Coagulating evidence for a new genetic link to drug responsiveness to warfarin therapyROSS, C. J. D.Clinical genetics. 2005, Vol 68, Num 4, pp 327-329, issn 0009-9163, 3 p.Article

Randomized trial of lottery-based incentives to improve warfarin adherenceKIMMEL, Stephen E; TROXEL, Andrea B; LOEWENSTEIN, George et al.The American heart journal. 2012, Vol 164, Num 2, pp 268-274, issn 0002-8703, 7 p.Article

Association of warfarin dose with genes involved in its action and metabolismWADELIUS, Mia; CHEN, Leslie Y; ERIKSSON, Niclas et al.Human genetics. 2007, Vol 121, Num 1, pp 23-34, issn 0340-6717, 12 p.Article

A Bayesian Dose-Individualization Method for WarfarinWRIGHT, Daniel F. B; DUFFULL, Stephen B.Clinical pharmacokinetics. 2013, Vol 52, Num 1, pp 59-68, issn 0312-5963, 10 p.Article

Warfarin-induced skin necrosisMUNGALSINGH, Catherine R; BOMFORD, Jamie; NAYAGAM, Jeremy et al.Clinical medicine. 2012, Vol 12, Num 1, pp 90-91, issn 1470-2118, 2 p.Article

Factor VII Levels and International Normalized Ratios in the Early Phase of Warfarin TherapyBENZON, Honorio T; AVRAM, Michael J; BENZON, Hubert A et al.Anesthesiology (Philadelphia). 2010, Vol 112, Num 2, pp 298-304, issn 0003-3022, 7 p.Article

Provision of warfarin education to hospital inpatientsBAUGHMAN, Christopher; SPURLING, Lisa; MANGONI, Arduino A et al.British journal of clinical pharmacology. 2008, Vol 66, Num 3, pp 416-417, issn 0306-5251, 2 p.Article

The story of the discovery of heparin and warfarinWARDROP, Douglas; KEELING, David.British journal of haematology. 2008, Vol 141, Num 6, pp 757-763, issn 0007-1048, 7 p.Article

Probable Interaction Between Warfarin and TorsemideBIRD, Jennifer; CARMONA, Carlos.The Annals of pharmacotherapy. 2008, Vol 42, Num 12, pp 1893-1898, issn 1060-0280, 6 p.Article

Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoringBEREZNICKI, Luke R; JACKSON, Shane L; PETERSON, Gregory M et al.Journal of clinical pathology. 2007, Vol 60, Num 3, pp 311-314, issn 0021-9746, 4 p.Article

Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patientsFIRRIOLO, F. John; HUPP, Wendy S.Oral surgery, oral medicine, oral pathology and oral radiology (Print). 2012, Vol 113, Num 4, pp 431-441, issn 2212-4403, 11 p.Article

Genetic Warfarin Dosing: Tables Versus AlgorithmsFINKELMAN, Brian S; GAGE, Brian F; JOHNSON, Julie A et al.Journal of the American College of Cardiology. 2011, Vol 57, Num 5, pp 612-618, issn 0735-1097, 7 p.Article

Using Pharmacogenetics in Real Time to Guide Warfarin Initiation: A Clinician UpdateCARLQUIST, John F; ANDERSON, Jeffrey L.Circulation (New York, N.Y.). 2011, Vol 124, Num 23, pp 2554-2559, issn 0009-7322, 6 p.Article

Cutaneous Surgery in Patients on Warfarin TherapyNELMS, Justin K; WOOTEN, Anna I; HECKLER, Frederick et al.Annals of plastic surgery. 2009, Vol 62, Num 3, pp 275-277, issn 0148-7043, 3 p.Article

Who is responsible for the care of patients treated with warfarin therapy?LOWTHIAN, Judy A; DIUG, Basia O; EVANS, Sue M et al.Medical journal of Australia. 2009, Vol 190, Num 12, pp 674-677, issn 0025-729X, 4 p.Article

Warfarin-induced skin necrosis of the eyelidsRAFIEI, Nastaran; TABANDEH, Homayoun; HIRSCHBEIN, Marc et al.Archives of ophthalmology (1960). 2007, Vol 125, Num 3, pp 421-421, issn 0003-9950, 1 p.Article

Optimal initial dose adjustment of warfarin in orthopedic patientsLENZINI, Petra A; GRICE, Gloria R; GAGE, Brian F et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 11, pp 1798-1804, issn 1060-0280, 7 p.Article

Polymorphisms in the VKORC1 gene are strongly associated with warfarin dosage requirements in patients receiving anticoagulationLI, T; LANGE, L. A; LI, X et al.Journal of medical genetics. 2006, Vol 43, Num 9, pp 740-744, issn 0022-2593, 5 p.Article

CΥP2C9 haplotype structure in European American warfarin patients and association with clinical outcomesVEENSTRA, David L; BLOUGH, David K; HIGASHI, Mitchell K et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 5, pp 353-364, issn 0009-9236, 12 p.Article

The challenge of regulating anticoagulant drugs: Focus on warfarinMANN, Kenneth G.The American heart journal. 2005, Vol 149, Num 1, pp S36-S42, issn 0002-8703, SUPArticle